Investments and Fair Value Measurement (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Investments |
Our investments on the condensed consolidated balance sheets consisted of the following (in millions): | | | | | | | | | | | | | | | | | As of | | | December 31, 2025 | | March 31, 2026 | | Classified as short-term investments: | | | | | Marketable debt securities (1): | | | | | | U.S. government and agency securities | | $ | 149 | | | $ | 143 | | | Commercial paper | | 75 | | | 62 | | | Corporate bonds | | 271 | | | 274 | | | | | | | | Asset-backed securities | | — | | | 17 | | | Certificates of deposit | | 33 | | | 37 | | | Short-term investments | | $ | 528 | | | $ | 533 | | | | | | | | Classified as restricted investments: | | | | | Marketable debt securities (1): | | | | | | U.S. government and agency securities | | $ | 6,830 | | | $ | 7,006 | | | Commercial paper | | 87 | | | 72 | | | Corporate bonds | | 1,897 | | | 1,843 | | | | | | | | | | | | | Certificates of deposit | | 38 | | | 87 | | | Mortgage-backed and asset-backed securities | | 22 | | | 18 | | | Restricted investments | | $ | 8,874 | | | $ | 9,026 | | | | | | | | Classified as investments: | | | | | | Non-marketable equity securities: | | | | | | Didi | | $ | 3,011 | | | $ | 2,337 | | Other (2) | | 1,455 | | | 1,800 | | | Marketable equity securities: | | | | | | Grab | | 2,674 | | | 1,961 | | Aurora (3) | | 1,252 | | | 1,343 | | | Other | | 667 | | | 569 | | Note receivable from a related party (2) | | 119 | | | 99 | | | Investments | | $ | 9,178 | | | $ | 8,109 | |
(1) Excluding marketable debt securities classified as cash equivalents and restricted cash equivalents. (2) These balances include certain investments recorded at fair value with changes in fair value recorded in earnings due to the election of the fair value option of accounting for financial instruments. (3) In connection with our exchangeable senior notes due in 2028 (the “2028 Exchangeable Senior Notes”), approximately 48% of our Aurora Innovation, Inc. (“Aurora”) Class A common stock is pledged as collateral and cannot be sold or transferred during the term of the 2028 Exchangeable Senior Notes until the obligations are fulfilled or the pledged assets are otherwise released under a collateral agreement. Refer to Note 5 – Long-Term Debt and Credit Arrangements for further information.
|
| Schedule of Assets and Liabilities Measured on Recurring Basis |
The following table presents our financial assets and liabilities measured at fair value on a recurring basis based on the three-tier fair value hierarchy (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | As of March 31, 2026 | | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Financial Assets | | | | | | | | | | | | | | | | | | Money market funds | | $ | 1,624 | | | $ | — | | | $ | — | | | $ | 1,624 | | | $ | 361 | | | $ | — | | | $ | — | | | $ | 361 | | | U.S. government and agency securities | | — | | | 7,323 | | | — | | | 7,323 | | | — | | | 7,344 | | | — | | | 7,344 | | | Commercial paper | | — | | | 715 | | | — | | | 715 | | | — | | | 217 | | | — | | | 217 | | | Corporate bonds | | — | | | 2,194 | | | — | | | 2,194 | | | — | | | 2,117 | | | — | | | 2,117 | | | Certificates of deposit | | — | | | 72 | | | — | | | 72 | | | — | | | 124 | | | — | | | 124 | | | Mortgage-backed and asset-backed securities | | — | | | 22 | | | — | | | 22 | | | — | | | 35 | | | — | | | 35 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Non-marketable equity securities | | — | | | — | | | 69 | | | 69 | | | — | | | — | | | 50 | | | 50 | | | Marketable equity securities | | 4,593 | | | — | | | — | | | 4,593 | | | 3,873 | | | — | | | — | | | 3,873 | | Note receivable from a related party | | — | | | — | | | 190 | | | 190 | | | — | | | — | | | 170 | | | 170 | | Derivative assets (1) | | — | | | — | | | — | | | — | | | — | | | 8 | | | 89 | | | 97 | | | Total financial assets | | $ | 6,217 | | | $ | 10,326 | | | $ | 259 | | | $ | 16,802 | | | $ | 4,234 | | | $ | 9,845 | | | $ | 309 | | | $ | 14,388 | | | Financial Liabilities | | | | | | | | | | | | | | | | | 2028 Exchangeable Senior Notes (2) | | $ | — | | | $ | 1,125 | | | $ | — | | | $ | 1,125 | | | $ | — | | | $ | 1,115 | | | $ | — | | | $ | 1,115 | | Derivative liabilities (1) | | — | | | 5 | | | — | | | 5 | | | — | | | 7 | | | — | | | 7 | | | | | | | | | | | | | | | | | | | | Total financial liabilities | | $ | — | | | $ | 1,130 | | | $ | — | | | $ | 1,130 | | | $ | — | | | $ | 1,122 | | | $ | — | | | $ | 1,122 | |
(1) Refer to Note 2 – Derivative and Hedging Instruments for further information. (2) Refer to Note 5 – Long-Term Debt and Credit Arrangements for further information.
|
| Schedule of Amortized Cost, Unrealized Gains and Losses and Fair Value of Debt Securities |
The following table summarizes the amortized cost, unrealized gains and losses, and fair value of our debt securities (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | As of March 31, 2026 | | | | Amortized Cost | | Unrealized Gains | | Unrealized Losses | | Fair Value | | Amortized Cost | | Unrealized Gains | | Unrealized Losses | | | Fair Value | | U.S. government and agency securities | | $ | 7,315 | | | $ | 8 | | | $ | — | | | $ | 7,323 | | | $ | 7,346 | | | $ | 2 | | | $ | (4) | | | | $ | 7,344 | | | Commercial paper | | 715 | | | — | | | — | | | 715 | | | 217 | | | — | | | — | | | | 217 | | | Corporate bonds | | 2,190 | | | 4 | | | — | | | 2,194 | | | 2,118 | | | 1 | | | (2) | | | | 2,117 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Certificates of deposit | | 72 | | | — | | | — | | | 72 | | | 124 | | | — | | | — | | | | 124 | | | Mortgage-backed and asset-backed securities | | 22 | | | — | | | — | | | 22 | | | 35 | | | — | | | — | | | | 35 | | | Total | | $ | 10,314 | | | $ | 12 | | | $ | — | | | $ | 10,326 | | | $ | 9,840 | | | $ | 3 | | | $ | (6) | | | | $ | 9,837 | |
|
| Schedule of Securities without Readily Determinable Fair Value |
The following table summarizes the total carrying value of our non-marketable equity securities measured at fair value on a non-recurring basis held, including cumulative unrealized upward and downward adjustments made to the initial cost basis of the securities (in millions): | | | | | | | | | | | | | | | | | As of | | | December 31, 2025 | | March 31, 2026 | | Initial cost basis | | $ | 2,673 | | | $ | 3,009 | | | Upward adjustments | | 3,726 | | | 3,755 | | | Downward adjustments (including impairment) | | (2,002) | | | (2,677) | | | Total carrying value at the end of the period | | $ | 4,397 | | | $ | 4,087 | |
|